Analyst Expectations for Zimmer Biomet Holdings's Future
Portfolio Pulse from Benzinga Insights
Zimmer Biomet Holdings (NYSE:ZBH) has received mixed analyst ratings in the last quarter, with 2 bullish, 3 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The average price target is $149.4, indicating potential upside from the current price of $118.075. The average price target has increased by 2.91% over the past month.
August 28, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zimmer Biomet Holdings has received mixed analyst ratings, with an average price target of $149.4, suggesting potential upside from the current price.
The mixed analyst ratings indicate uncertainty about the company's future performance. However, the average price target, which is higher than the current price, suggests that analysts see potential for the stock's price to increase. This could have a positive impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100